The urology business area investigates and treats patients with kidney, urinary tract, bladder, prostate, urethra, penis and testicular diseases. The operations are broad with both emergency and planned surgery, but many urological diseases can be treated without surgery.
Urologist to the rescue of men’s health
Urology is the branch of medicine that deals with the protection and reproductive and sexual health of the male genital organ, helping man in his biological and psychic development. Compared to its female counterpart (gynecology) it is a rather recent science – we start talking about urology in the late sixties – and there are no official academic specializations, but some doctors specializing in urology and endocrinology are dedicated to this field.
Urology uses these specialists for the diagnosis and therapy of the pathologies treated, but not only. In fact, only through the health of the body combined with that of the mind is it possible to achieve the health and well-being of the genital system. For this reason, urology deals with pathologies related to the male apparatus, approaching them not only under the surgical aspect, but also through information dialogue and listening, to examine the psychological and emotional relevance that this type of disorder can have on the patient. The pathologies most treated by urology include erectile dysfunction, premature or delayed ejaculation, infertility, testicular tumors, sexually transmitted diseases, twisting and testicular trauma. Urology also pays close attention to the prevention of certain pathologies related to the male genital organs, to the information of contraception systems and to responsible parenthood. Prostatic pathologies and andropause are also treated by urologists, bringing even older men closer to this medical branch.
Urology products
The range of pharmacological products available for urology and andrology patients matches the expert services we provide. You can look them up by name or category on the Products list.
The range of pharmacological products available for urology and andrology patients follows the same clinical logic as the specialist services provided in this area. The Products list allows patients to look up medicines by name or by treatment category, which is useful when a patient already knows the prescribed product, needs to compare available strengths, or wants to understand which medicines are commonly used for urinary, prostate, sexual, hormonal, or reproductive concerns.
Urological treatment often begins before surgery is considered. NIDDK describes urologic diseases as conditions affecting the urinary tract, including urinary tract infections, kidney stones, bladder control problems, and prostate problems, which means medication therapy can be relevant across both acute and long-term care. In male health, pharmacological treatment may also support erectile function, ejaculation control, fertility evaluation, androgen-related disorders, prostate symptoms, inflammation, and selected infections when the diagnosis supports drug therapy.
The main product groups usually include:
- PDE5 inhibitors for erectile dysfunction, such as sildenafil, tadalafil, vardenafil, and avanafil, prescribed after review of cardiovascular status, nitrate use, blood pressure treatment, and sexual health history
- Alpha-blockers and 5-alpha reductase inhibitors for benign prostatic hyperplasia, where treatment may improve urine flow, reduce prostate-related symptoms, or slow progression depending on the medicine selected
- Antibiotics and urinary anti-infective medicines for confirmed or strongly suspected bacterial infections, with attention to culture results, allergy history, kidney function, and resistance risk
- Anti-inflammatory and pain-control medicines used in kidney stone episodes, prostatitis evaluation, testicular pain, or post-procedure recovery when clinically appropriate
- Hormonal and fertility-related medicines used only after laboratory testing, semen analysis, endocrine review, or specialist assessment
For erectile dysfunction, the American Urological Association states that men should be informed about FDA-approved oral PDE5 inhibitors unless contraindications apply, including discussion of benefits and risks.
For prostate enlargement, MedlinePlus and Mayo Clinic describe 5-alpha reductase inhibitors such as finasteride and dutasteride as medicines that act by blocking hormone changes involved in prostate growth.
The products list should therefore be used as an information and access tool, not as a substitute for diagnosis. The correct product depends on the organ involved, the symptom pattern, laboratory findings, age, reproductive goals, current medicines, and the level of risk attached to the condition.